LINC00930 and nasopharyngeal carcinoma: For example, LINC00930, an oncogenic lncRNA in nasopharyngeal carcinoma, promoted PFKFB3‐mediated glycolysis and histone modification, and targeting LINC00930 and PFKFB3 may be an effective approach to enhance radiosensitivity in patients with nasopharyngeal carcinoma.26